Clinical Trials Directory

Trials / Completed

CompletedNCT01530685

Gycabiane and Glycemic Control of Prediabetic Subjects

Effect of Glycabiane, a Dietary Supplement, on Glycemic Control of Prediabetic Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
83 (actual)
Sponsor
PiLeJe · Industry
Sex
All
Age
25 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to examine the effects of supplementation Glycabiane, a dietary supplement, on glycemic control of overweight prediabetic subjects.

Detailed description

Cinnamon's effects on blood glucose have been the subject of many clinical and animal studies; however, the issue of cinnamon intake's effect on fasting blood glucose (FBG) in people with prediabetes still remains unclear. The main purpose of this study is to examine the effects of supplementation with Glycabiane, a dietary supplement rich in cinnamon extract, on fast blood glucose of overweight prediabetic subjects in a randomized, placebo-controlled, clinical trial.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGlycabiane2 gelule per day for 4 months
DIETARY_SUPPLEMENTplacebo2 gelules per day for 4 months

Timeline

Start date
2011-10-27
Primary completion
2012-09-25
Completion
2012-09-25
First posted
2012-02-10
Last updated
2021-04-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01530685. Inclusion in this directory is not an endorsement.